GlobeNewswire

FLSmidth announces MissionZero to reduce emissions in cement and mining by 2030

Share

PRESS RELEASE, COPENHAGEN, DENMARK - NOVEMBER 6, 2019

At its Capital Markets Day held in Copenhagen today, FLSmidth launched MissionZero, a new sustainability programme aimed at significantly reducing emissions across the global cement and mining industries by 2030.

“With economic growth, urbanisation and growing populations comes the demand for infrastructure, such as housing, schools, hospitals and roads. Added to this, modern conveniences such as air conditioning, appliances and smartphones are high in demand, and renewable energy options such as electric cars, wind and solar energy are looked to as the future. All of that requires cement and minerals, and demand will only continue to rise. Today, we launch MissionZero to seize the opportunity to increase production and at the same time drive emissions towards zero,” said Thomas Schulz, Group CEO, FLSmidth. 

Central to MissionZero is FLSmidth’s focus on enabling its customers in cement and mining to move towards zero emissions in 2030. The company will do so by leveraging the development of digital and innovative solutions tied to sustainable productivity, offering its customers the required technological solutions to:

  • operate zero emissions cement plants by 2030
  • manage zero emissions mining processes by 2030 – with specific focus on water management

Towards zero emissions in cement
FLSmidth estimates that it can reduce the CO2 emissions per kg cement by approximately 70% by 2030 by leveraging opportunities within existing pioneering technologies, innovation projects and early-stage R&D. To achieve this, FLSmidth is developing solutions such as blending clinker with alternative materials, exploring the use of new types of cements and providing solutions to cement producers to operate 100% alternative fuelled cement plants including waste-to-energy solutions.

In addition, FLSmidth will accelerate solutions to close the remaining gap (30%). As these solutions do not exist today, FLSmidth will actively seek knowledge partnerships with other companies and suppliers to co-create solutions.

Towards a waterless mining process
Water is a scarce resource in many parts of the world and represents a rising cost for FLSmidth’s mining customers. The company has set a goal to offer its customers solutions that support zero water waste by 2030, building on the success of recent developments, such as its dry-stack tailings solution (DST). Utilising DST can recover up to 95% of process water while being economically competitive with alternative water management options such as desalination, even for high tonnages.

Ambitious goals require collaborative efforts
”With MissionZero, we commit to our most ambitious goals to date. We are doing it because it is necessary, because it is sound business, and because it provides us with a competitive edge. We are the go-to-partner for sustainable productivity, and are perfectly positioned to address the challenges our customers face such as rising costs, tighter regulations and increased societal expectations. MissionZero goes beyond what is feasible today, and requires a paradigm shift in how industry players collaborate and innovate. As a leader in the cement and mining industries, we have a responsibility to accelerate the adoption of sustainable solutions,” said Thomas Schulz.

Underlining its commitment to drive sustainable solutions, FLSmidth was among the first companies to join the GCCA’s Innovandi - Global Cement and Concrete Research Network. This new network brings together the cement and concrete industry with scientific institutions to drive and support global innovation with actionable research. Its aims to decisively build on the industry’s sustainability progress with the focus on reducing emissions and achieving better use of alternative fuels.

MissionZero by FLSmidth

Accelerating solutions to reduce emissions in cement and mining by 2030
Goals for Cement

FLSmidth will develop solutions that will enable our customers to operate cement plants with:
  • Zero emissions
  • 100% fuel substitution
  • Zero waste
Goals for Mining

FLSmidth will develop solutions that will enable our customers to manage mining processes with:
  • Zero water waste
  • Zero emissions
  • Zero energy waste

Contacts

Media Relations
Fleming Voetmann, + 53 81 51 28, fvo@flsmidth.com


Investor Relations
Nicolai Mauritzen, +45 30 93 18 51, nicm@flsmidth.com

FLSmidth delivers sustainable productivity to the global mining and cement industries. We deliver market-leading engineering, equipment and service solutions to our customers enabling them to improve performance, drive down costs and reduce environmental impact. Our operations span the globe and our 11,400 employees are present in more than 60 countries. In 2018, FLSmidth generated revenue of DKK 18.8 billion. www.flsmidth.com

Attachment

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

LIDDS Liproca® Depot Phase IIb study results presented at EMUC19 showing both primary and secondary endpoints being met16.11.2019 10:10:00 CETPress release

UPPSALA, SWEDEN – LIDDS AB (publ) Phase IIb clinical data from the LPC-004 prostate cancer study on LIDDS Liproca® Depot were presented today in an oral session at the 11th European Multidisciplinary Congress on Urological Cancers, EMUC19. The study met both its primary and secondary endpoints as well as demonstrated that a larger proportion of intermediate risk patients, which is the Liproca Depot target group, are PSA responders. The presentation can be accessed through LIDDS webpage and are also attached to this release. The phase IIb results from the LPC-004 prostate cancer study was presented as “Late Breaking News” at EMUC in Vienna on November 16, 2019 by Professor Laurence Klotz, a world leading expert in Active Surveillance of prostate cancer patients. Professor Klotz was one of the LPC-004 study investigators and is Professor at the University of Toronto Division of Urology at the Sunnybrook Health Sciences Centre in Canada. The preliminary data recently released from the pha

AMG Advanced Metallurgical Group N.V. Completes Acquisition of International Specialty Alloys15.11.2019 23:30:00 CETPress release

Amsterdam, 15 November 2019 --- AMG Advanced Metallurgical Group N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") has finalized the acquisition of the assets of International Specialty Alloys ("ISA"), a leading U.S. producer of titanium master alloys and other binary alloys for the aerospace market, from Kennametal, Inc. The acquisition was previously announced on October 9, 2019 and closed and became effective today. About AMG AMG is a global critical materials company at the forefront of CO2 reduction trends. AMG produces highly engineered specialty metals and mineral products and provides related vacuum furnace systems and services to the transportation, infrastructure, energy, and specialty metals & chemicals end markets. AMG Critical Materials produces aluminum master alloys and powders, ferrovanadium, natural graphite, chromium metal, antimony, lithium, tantalum, niobium and silicon metal. AMG Technologies produces titanium aluminides and titanium alloys for the aerospace market; designs,

New Novartis medicine Adakveo® (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease15.11.2019 21:06:00 CETPress release

Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications1 Adakveo reduced the annual rate of sickle cell pain crises by 45% compared to placebo (1.63 vs 2.98) and the annual rate of days hospitalized (4 vs 6.87) in a 52-week study2 Approximately 100,000 people in the United States, most of whom are of African descent, have sickle cell disease3 Approval comes approximately two months ahead of FDA’s priority review action date, allowing Adakveo to be available to patients more quickly Basel, November 15, 2019 – Novartis announced today that the US Food and Drug Administration (FDA) approved Adakveo ® (crizanlizumab), previously known as SEG101, to reduce the frequency of vaso-occlusive crises (VOCs), or pain crises, in adult and pediatric patients aged 16 years and older with sickle cell disease.4 Adakveo represents the first FDA-approved medicine in sickle cell disease that binds to P-selectin –a cell adhesion protein that plays a central r

SFL - Invitation to Presentation of Q3 2019 Results15.11.2019 20:06:00 CETPress release

SFL Corporation Ltd. ("SFL" or the “Company”) (NYSE: SFL) plans to release its preliminary financial results for the third quarter of 2019 on Thursday, November 21, 2019. SFL plans to host a conference call and webcast for all stakeholders and interested parties on Thursday, November 21, 2019 at 10:00 AM (EST) / 4:00 PM (CET). Relevant material will be available from the Investor Relations section of the Company’s website at www.sflcorp.com on the same day. In order to listen to the presentation you may do one of the following: A: Webcast Visit the Investor Relations section of the Company’s website at www.sflcorp.com and click on the link to "Webcast". The webcast with slideshow will be played live from this platform. To listen to the conference call from the website, you need to have installed Windows Media Player, and you need to have a sound card on your computer. B: Conference Call Participants dial-in details: US Toll Free telephone number +1 866 966 1396 International Dial-in te

Cavotec’s Nomination Committee ahead of Annual General Meeting 202015.11.2019 18:00:00 CETPress release

The Nomination Committee of Cavotec SA (“Cavotec”) consists of members appointed by Cavotec’s Board of Directors, in accordance with Cavotec's Internal Regulations. The composition of the members of the Nomination Committee presented below is in line with the recommendations of the Swedish Corporate Governance Code. The main purpose and responsibility of the Nomination Committee is to present proposals for the election and remuneration of the Chairman and the Board of Directors as well as the Auditors to the Annual General Meeting 2020. The Board of Directors has decided that the four largest shareholders and the Chairman of Cavotec’s Board of Directors shall be represented in the Nomination Committee. On 31 October 2019, the four largest shareholders recorded in the company’s share register were Bure Equity AB (27.1% of the vote), AP4 (9.8% of the vote), Nomina SA (8.1% of the vote) and Founding Shareholders (Stefan Widegren, Lars Hellman and Peter Brandel with families) (11.9 % of th

Touax: Nine-Month Revenue From Activities: +4.9%15.11.2019 17:45:00 CETPress release

PRESS RELEASE Paris, 15 November 2019 – 5.45 p.m. YOUR OPERATIONAL LEASING SOLUTION NINE-MONTH REVENUE FROM ACTIVITIES: +4.9% Revenue 1 up 1.4% in the third quarter of 2019, Revenue up 4.9% over the first nine months of the year (+1.5% at constant scope and currency) validating the group’s strategic objectives ANALYSIS OF REVENUE FROM ACTIVITIES Q3 2019 revenue totalled €40.1 million vs. €39.6 million in Q3 2018, an increase of 1.4%. Over the first nine months of the year, revenue from activities totalled €119.6 million (€115.7 million at constant scope and currency), up 4.9% compared to the same period in 2018. Revenue from leasing activities amounted to 99.8 million euros (96.8 million euros at constant scope and currency) at 30 September 2019, including a 10% increase in the Leasing Revenue on owned equipment (36.9 million euros). Leasing Revenue from leasing activities stood at 99.9 million euros in the first nine months of 2018. Sales rose to €19 million (€14.2 million at constant